U.S. markets closed

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.4900-0.0400 (-1.13%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 1/12/2021
Current
9/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
357.59M307.84M477.81M398.12M387.74M
Enterprise Value 3
230.59M192.98M376.93M304.25M312.21M
Trailing P/E
5.157.6211.2712.8341.67
Forward P/E 1
9.866.8313.3910.138.24
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
3.112.654.153.995.42
Price/Book (mrq)
2.282.774.794.544.97
Enterprise Value/Revenue 3
1.956.5812.7310.4410.36
Enterprise Value/EBITDA 6
5.5416.3634.3628.2337.72

Trading Information

Stock Price History

Beta (5Y Monthly) 1.53
52-Week Change 3-15.29%
S&P500 52-Week Change 313.47%
52 Week High 35.2800
52 Week Low 32.5500
50-Day Moving Average 33.5409
200-Day Moving Average 33.6169

Share Statistics

Avg Vol (3 month) 31.66M
Avg Vol (10 day) 31.58M
Shares Outstanding 5103.65M
Float 86.41M
% Held by Insiders 16.98%
% Held by Institutions 169.58%
Shares Short (Dec 30, 2020) 410.16M
Short Ratio (Dec 30, 2020) 45.02
Short % of Float (Dec 30, 2020) 410.54%
Short % of Shares Outstanding (Dec 30, 2020) 49.80%
Shares Short (prior month Nov 29, 2020) 412.82M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 60.48%
Operating Margin (ttm)34.43%

Management Effectiveness

Return on Assets (ttm)18.73%
Return on Equity (ttm)60.93%

Income Statement

Revenue (ttm)118.18M
Revenue Per Share (ttm)1.14
Quarterly Revenue Growth (yoy)-5.10%
Gross Profit (ttm)87.55M
EBITDA 40.79M
Net Income Avi to Common (ttm)71.48M
Diluted EPS (ttm)0.6700
Quarterly Earnings Growth (yoy)218.00%

Balance Sheet

Total Cash (mrq)127.11M
Total Cash Per Share (mrq)1.23
Total Debt (mrq)114.56k
Total Debt/Equity (mrq)0.07
Current Ratio (mrq)7.86
Book Value Per Share (mrq)1.51

Cash Flow Statement

Operating Cash Flow (ttm)44.22M
Levered Free Cash Flow (ttm)29.94M